老年复杂冠心病血运重建后10年随访
本研究为SYNTAX Extended Survival研究预先设定的年龄分析,纳入1,800例随机患者,其中575例(31.9%)为老年(>70岁)三支病变和/或左主干病变患者。比较PCI与CABG后10年全因死亡、5年MACCE、预期寿命和5年生活质量,发现老年患者两种血运重建方式在上述终点均无显著差异。
要点
- 老年3VD/LMD患者PCI与CABG的10年全因死亡率无显著差异(44.1% vs 41.1%)。
- 老年患者5年MACCE在PCI与CABG间相当(39.4% vs 35.1%)。
- 老年患者预期寿命和5年生活质量在PCI与CABG间无显著差异。
核心结论
- 老年3VD和/或LMD患者无论采用PCI还是CABG,10年全因死亡、预期寿命、5年MACCE和5年生活质量均相当。
研究设计与样本
- SYNTAX Extended Survival研究预先设定的年龄分析,纳入1,800例随机患者,575例(31.9%)为老年(>70岁)。
- 比较老年与非老年患者PCI与CABG的10年全因死亡和5年MACCE,采用Kaplan-Meier估计和Cox比例风险模型。
- 预期寿命采用10年内限制性平均生存时间估计,5年生活质量采用西雅图心绞痛问卷和线性混合效应模型评估。
主要发现
- 老年患者10年死亡率PCI与CABG无显著差异(44.1% vs 41.1%;HR 1.08;95%CI 0.84-1.40)。
- 非老年患者10年死亡率PCI与CABG无显著差异(21.1% vs 16.6%;HR 1.30;95%CI 1.00-1.69;交互P=0.332)。
- 老年患者5年MACCE在PCI与CABG间相当(39.4% vs 35.1%;HR 1.18;95%CI 0.90-1.56)。
- 非老年患者5年MACCE PCI显著高于CABG(36.3% vs 23.0%;HR 1.69;95%CI 1.36-2.10;交互P=0.043)。
- 老年患者预期寿命(平均差0.2年 favoring CABG;95%CI -0.4至0.7)和5年生活质量在PCI与CABG间无显著差异。
临床怎么用
- 对于老年(>70岁)3VD和/或LMD患者,PCI与CABG的10年死亡、5年MACCE、预期寿命和5年生活质量相当,血运重建方式选择需个体化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal revascularization strategy for the elderly with complex coronary artery disease remains unclear. OBJECTIVES: The goal of this study was to investigate 10-year all-cause mortality, life expectancy, 5-year major adverse cardiac or cerebrovascular events (MACCE), and 5-year quality of life (QOL) after percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) in elderly individuals (>70 years old) with 3-vessel disease (3VD) and/or left main disease (LMD). METHODS: In the present pre-specified analysis on age of the SYNTAX Extended Survival study, 10-year all-cause death and 5-year MACCE were compared with Kaplan-Meier estimates and Cox proportional hazards models among elderly or nonelderly patients. Life expectancy was estimated by restricted mean survival time within 10 years, and QOL status according to the Seattle Angina Questionnaire up to 5 years was assessed by linear mixed-effects models. RESULTS: Among 1,800 randomized patients, 575 patients (31.9%) were elderly. Ten-year mortality did not differ significantly between PCI and CABG in elderly (44.1% vs. 41.1%; hazard ratio [HR]: 1.08; 95% confidence interval [CI]: 0.84 to 1.40) and nonelderly patients (21.1% vs. 16.6%; HR: 1.30; 95% CI: 1.00 to 1.69; pinteraction = 0.332). Among elderly patients, 5-year MACCE was comparable between PCI and CABG (39.4% vs. 35.1%; HR: 1.18; 95% CI: 0.90 to 1.56), whereas it was significantly higher in PCI over CABG among nonelderly patients (36.3% vs. 23.0%; HR: 1.69; 95% CI: 1.36 to 2.10; pinteraction = 0.043). There were no significant difference in life expectancy (mean difference: 0.2 years in favor of CABG; 95% CI: -0.4 to 0.7) and 5-year QOL status between PCI and CABG among elderly patients. CONCLUSIONS: Elderly patients with 3VD and/or LMD had comparable 10-year all-cause death, life expectancy, 5-year MACCE, and 5-year QOL status irrespective of revascularization mode. (Synergy Between PCI With TAXUS and Cardiac Surgery: SYNTAX Extended Survival [SYNTAXES]; NCT03417050) (SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries [SYNTAX]; NCT00114972).
引用
- Ono M, Serruys PW, Hara H, et al. 10-Year Follow-Up After Revascularization in Elderly Patients With Complex Coronary Artery Disease. J Am Coll Cardiol. 2021. PMID: 34082905. doi:10.1016/j.jacc.2021.04.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。